who r lonzo...

Lonza is one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries. Products and services span its customers’ needs from research to final product manufacture. It is the global leader in the production and support of active pharmaceutical ingredients both chemically as well as biotechnologically. Biopharmaceuticals are one of the key growth drivers of the pharmaceutical and biotechnology industries. Lonza has strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important role in the development of novel medicines and healthcare products. In addition, Lonza is a leader in cell-based research, endotoxin detection and cell therapy manufacturing. Furthermore, the company is a leading provider of value chemical and biotech ingredients to the nutrition, hygiene, preservation, agro and personal care markets.

Lonza is headquartered in Basel, Switzerland and is listed on the SIX Swiss Exchange. In 2010, the company had sales of CHF 2.680 billion. ............(ME) But Singapore is where its all going to happen.. This deal along with every agreement and contract MSB enters into gets better and better, Singapore are so keen to build its life/Science World best practices hub,Tax advantages will be very benifical to MSB,s cause ..Lonza went thru this scenero some 3 years ago with a company much the same deal but in the mean time Roche took over the involved company and paid 190 mill to lonza for the plant .. .. which was a bargin ... ps. Dont give a damm where ww markets go, take no notice of daily sp .. This is a buy, or a hold for investors with no money to buy... Cheers holders and others who may enter now or years to come .....V